Five-Day Changes in Biomarkers of Exposure among Adult Smokers after Completely Switching from Combustible Cigarettes to a Nicotine-Salt Pod System

Nicotine and Tobacco Research

Volumn 22, Issue 8, 2020, Pages 1285-1293

  Jay, Joanna ^a   Pfaunmiller, Erika L ^b   Huang, Norman J ^a   Cohen, Gal ^a   Graff, Donald W ^a  

^a JUUL Labs San Francisco   (United States)

^b CELERION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TOBACCO SMOKE; CARCINOGEN; INORGANIC SALT; NICOTINE;

ADULT; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; EXPOSURE; FEMALE; HUMAN; MALE; NORMAL HUMAN; OPEN STUDY; PARALLEL DESIGN; PERSONAL EXPERIENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; STUDY DESIGN; CALIFORNIA; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; MIDDLE AGED; PSYCHOLOGY; SMOKE; SMOKING; TOBACCO; URINE; YOUNG ADULT;

ADULT; CARCINOGENS; CIGARETTE SMOKING; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MIDDLE AGED; NICOTINE; SALTS; SAN FRANCISCO; SMOKE; SMOKERS; TOBACCO PRODUCTS; YOUNG ADULT;

EID: 85086759836     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntz206     Document Type: Article

References (42)

1. U.S. Department of Health and Human Services. The Health Consequences of Smoking - 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Published 2014. Accessed June 16, 2019
2. Wald NJ, Hackshaw AK. Cigarette smoking: An epidemiological overview. Br Med Bull. 1996;52(1):3-11
3. Mattes W, Yang X, Orr MS, Richter P, Mendrick DL. Biomarkers of tobacco smoke exposure. Adv Clin Chem. 2014;67:1-45
4. D Ruiz CD, Graff DW, Robinson E. Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes. BMC Public Health. 2016;16(1):543
5. The National Academies of Science Engineering Medicine. Public Health Consequences of E-cigarettes. NASEM Consensus Report 2018. Published January 2018. http://nationalacademies.org/hmd/reports/2018/publichealth-consequences-of-e-cigarettes.aspx. Accessed June 16, 2019
6. McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes: An Evidence Update. A report commissioned by Public Health England. Published August. London: Public Health England; 2015
7. Polosa R, Morjaria J, Caponnetto P, et al. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health. 2014;11(5):4965-4977
8. Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P 3rd, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: A longitudinal within-subjects observational study. Nicotine Tob Res. 2017;19(2):160-167
9. Saitta D, Chowdhury A, Ferro GA, Nalis FG, Polosa R. A risk assessment matrix for public health principles: The case for e-cigarettes. Int J Environ Res Public Health. 2017;14(4). doi:10.3390/ijerph14040363
10. Goniewicz ML, Smith DM, Edwards KC, et al. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open. 2018;1(8):e185937
11. Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T. Interventions to reduce harm from continued tobacco use. Ireland, Europe: John Wiley & Sons Ltd; 2016
12. Franck C, Filion KB, Kimmelman J, Grad R, Eisenberg MJ. Ethical considerations of e-cigarette use for tobacco harm reduction. Respir Res. 2016;17(1):53
13. Latif E, Nair M. E-cigarettes: A need to broaden the debate. Int J Tuberc Lung Dis. 2016;20(11):1430-1435
14. Fagerstrom KO, Bridgman K. Tobacco harm reduction: The need for new products that can compete with cigarettes. Addict Behav. 2014;39(3):507-511
15. Nollen NL, Mayo MS, Clark L, et al. Tobacco toxicant exposure in cigarette smokers who use or do not use other tobacco products. Drug Alcohol Depend. 2017;179(1):330-336
16. Gilman G, Johnson MS, Martin A, et al. Characterization of temperature regulation and HPHC profile of a nicotine salt-based ENDS product. In: SNRT Conference; 2018. JLIscience.com. Accessed June 2019
17. Gilman G, Johnson M, Martin A, et al. Characterization of temperature regulation and HPHC profile of a nicotine-salt based ENDS product. Poster session presented at: Society for Research on Nicotine and Tobacco Conference; February 21-24, 2018; Baltimore, MD
18. Gilman G, Johnson M, Martin A, et al. HPHC analysis of eight flavors of a temperature-regulated nicotine salt-based ENDS product. Poster session presented at: Global Forum on Nicotine Conference; 2018 June 14-16; Warsaw, Poland
19. Wynne C, Waaka DS, Devonie S. Acute use of nicotine salt-based ENDS and combusted cigarettes. Poster session presented at: Society for Research on Nicotine and Tobacco 24th Annual Meeting; 2018 February 21-24; Baltimore, MD
20. Lexicomp. Drug Information Handbook: A Clinically Relevant Resource for All Healthcare. 24th ed. Hudson, OH: Wolters Kluwer, Inc.; 2015
21. Leslie Kux. Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List. Food and Drug Administration. https://www.fda.gov/tobacco-products/rules-regulationsand-guidance/harmful-And-potentially-harmful-constituents-Tobaccoproducts-and-Tobacco-smoke-established-list. Published April 2012. Accessed September 2019
22. Yan XS, D Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol. 2015;71(1):24-34
23. Round EK, Chen P, Taylor AK, Schmidt E. Biomarkers of tobacco exposure decrease after smokers switch to an e-cigarette or nicotine gum. Nicotine Tob Res. 2019;21(9):1239-1247
24. Hecht SS, Carmella SG, Kotandeniya D, et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res. 2015;17(6):704-709
25. Smith SS, Piper ME, Bolt DM, et al. Development of the brief Wisconsin inventory of smoking dependence motives. Nicotine Tob Res. 2010;12(5):489-499
26. Hecht SS, Carmella SG, Chen M, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 1999;59(3):590-596
27. Lorkiewicz P, Riggs DW, Keith RJ, et al. Comparison of urinary biomarkers of exposure in humans using electronic cigarettes, combustible cigarettes, and smokeless tobacco. Nicotine Tob Res. 2019;21(9):1228- 1238. doi:10.1093/ntr/nty089
28. Campbell LR, Brown BG, Jones BA, Marano KM, Borgerding MF. Study of cardiovascular disease biomarkers among tobacco consumers, part 1: biomarkers of exposure. Inhal Toxicol. 2015;27(3):149-156
29. St Helen G, Shahid M, Chu S, Benowitz NL. Impact of e-liquid flavors on e-cigarette vaping behavior. Drug Alcohol Depend. 2018;189(1):42-48
30. St Helen G, Dempsey DA, Havel CM, Jacob P 3rd, Benowitz NL. Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes. Drug Alcohol Depend. 2017;178(1):391-398
31. Robinson RJ, Hensel EC, Al-Olayan AA, Nonnemaker JM, Lee YO. Effect of e-liquid flavor on electronic cigarette topography and consumption behavior in a 2-week natural environment switching study. PLoS One. 2018;13(5):e0196640
32. Koszowski B, Rosenberry ZR, Kanu A, Viray LC, Potts JL, Pickworth WB. Nicotine and carbon monoxide exposure from inhalation of cigarillo smoke. Pharmacol Biochem Behav. 2015;139(Pt A):7-14
33. Choi K, Sabado M, El-Toukhy S, Vogtmann E, Freedman ND, Hatsukami D. Tobacco product use patterns, and nicotine and tobaccospecific nitrosamine exposure: NHANES 1999-2012. Cancer Epidemiol Biomarkers Prev. 2017;26(10):1525-1530
34. Chang CM, Edwards SH, Arab A, Del Valle-Pinero AY, Yang L, Hatsukami DK. Biomarkers of tobacco exposure: summary of an FDA-sponsored public workshop. Cancer Epidemiol Biomarkers Prev. 2017;26(3):291-302
35. Conklin DJ, Malovichko MV, Zeller I, et al. Biomarkers of chronic acrolein inhalation exposure in mice: implications for tobacco productinduced toxicity. Toxicol Sci. 2017;158(2):263-274
36. Hecht SS, Stepanov I, Carmella SG. Exposure and metabolic activation biomarkers of carcinogenic tobacco-specific nitrosamines. Acc Chem Res. 2016;49(1):106-114
37. Rostron BL, Chang CM, van Bemmel DM, Xia Y, Blount BC. Nicotine and toxicant exposure among U.S. smokeless tobacco users: results from 1999 to 2012 National Health and Nutrition Examination Survey Data. Cancer Epidemiol Biomarkers Prev. 2015;24(12):1829-1837
38. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med. 2015;372(4):392-394
39. Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380(7):629-637
40. Stepanov I, Carmella SG, Briggs A, et al. Presence of the carcinogen N?-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res. 2009;69(21):8236-8240
41. Stepanov I, Carmella SG, Han S, et al. Evidence for endogenous formation of N?-nitrosonornicotine in some long-Term nicotine patch users. Nicotine Tob Res. 2009;11(1):99-105
42. Smith TT, Wahlquist AE, Heckman BW, Cummings KM, Carpenter MJ. Impact of e-cigarette sampling on cigarette dependence and reinforcement value. Nicotine Tob Res. 2018. doi:10.1093/ntr/nty258